Polymerase domain B mutation is associated with hepatitis relapse during long-term lamivudine therapy for chronic hepatitis B. (Q46604917)
Jump to navigation
Jump to search
scientific article published in November 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Polymerase domain B mutation is associated with hepatitis relapse during long-term lamivudine therapy for chronic hepatitis B. |
scientific article published in November 2005 |
Statements
1 reference
Polymerase domain B mutation is associated with hepatitis relapse during long-term lamivudine therapy for chronic hepatitis B. (English)
1 reference
Namiki Izumi
1 reference
Hiroyuki Nakanishi
1 reference
Masayuki Kurosaki
1 reference
Yasuhiro Asahina
1 reference
Yuko Onuki
1 reference
Ken Ueda
1 reference
Yuki Nishimura
1 reference
Kaoru Tsuchiya
1 reference
Takatoshi Kitamura
1 reference
Masakatsu Uchihara
1 reference
Shozo Miyake
1 reference
Nobuyuki Enomoto
1 reference
1 November 2005
1 reference
1 reference
48
1 reference
6
1 reference
381-388
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference